Darlene Ann Dunay, DO
Family Medicine · Old Forge, PANPI 1356458574
Payments from drug & device makers
Across 1,281 payments — averaging $45.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$26K
- Eisai Inc.$9K
- AstraZeneca$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- Johnson & Johnson$2K
- Novo Nordisk$2K
- plus $14K from 54 others
What the payments were for
- Consulting fees$3,7056%
- Speaking & faculty fees$22,78539%
- Travel & lodging$6,10811%
- Food & beverage$25,04143%
- Education$2610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$22,666
- Leqembi$8,048
- XIFAXAN$2,260
- FARXIGA$928
- XARELTO$862
- Rinvoq$492
- Auvelity$373
- AIRSUPRA$351
- PRESTIGE LP CERVICAL DISC SYSTEM$288
- VOQUEZNA$251
- NEXLIZET$250
- NEXLETOL$250
- UPTRAVI$244
- OPSUMIT$244
- RYBELSUS$242
- Kerendia$240
- SYMPLICITY G3$171
- GENERAL PAIN MANAGEMENT$137
- Ozempic$125
- TRELEGY ELLIPTA$125
How this compares
$57,901 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 225 | $144,463 |
| OzempicSemaglutide | 78 | $85,307 |
| RexultiBrexpiprazole | 46 | $55,193 |
| JardianceEmpagliflozin | 61 | $48,236 |
| XareltoRivaroxaban | 59 | $41,084 |
| MounjaroTirzepatide | 23 | $35,103 |
| Xtampza ErOxycodone Myristate | 16 | $27,294 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $23,750 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 59 | $22,992 |
| OxycontinOxycodone Hcl | 14 | $19,527 |
| MyrbetriqMirabegron | 44 | $18,686 |
| FarxigaDapagliflozin Propanediol | 20 | $15,297 |
| Breo ElliptaFluticasone/Vilanterol | 30 | $14,735 |
| EntrestoSacubitril/Valsartan | 18 | $14,021 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $13,197 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $1,081 | $144,463225 claims |
| Novo NordiskOzempic | $1,692 | $85,30778 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $44 | $59,63079 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $615 | $55,19346 claims |
| Johnson & JohnsonXarelto | $2,395 | $41,08459 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $375 | $38,48469 claims |
| Lilly USA, LLCMounjaro | $556 | $35,10323 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $412 | $27,29416 claims |
| Astellas Pharma US IncMyrbetriq | $471 | $18,68644 claims |
| AstraZenecaFarxiga | $2,752 | $15,29720 claims |
| NovartisEntresto | $299 | $14,02118 claims |
| AbbVieNamzaric, Synthroid | $25,837 | $13,94090 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Old Forge
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.